Investing.com - Nurix (NASDAQ: NRIX) reported third quarter EPS of $-0.67, in line with the analyst estimate of $-0.67. Revenue for the quarter came in at $12.6M versus the consensus estimate of $14.98M.
Nurix's stock price closed at $23.63. It is up 8.54% in the last 3 months and up 270.96% in the last 12 months.
Nurix saw 3 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Nurix's stock price’s past reactions to earnings here.
According to InvestingPro, Nurix's Financial Health score is "fair performance".
Check out Nurix's recent earnings performance, and Nurix's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar